Trends in prostate cancer screening in the pre- and peri-COVID-19 Pandemic period.
Matthew James DavisAlex StephensMohit ButaneyChase MorrisonNicholas CorsiAkshay SoodAlbert M LevinAlexander ColeQuoc-Dien TrinhCraig RogersFiras AbdollahPublished in: Urology practice (2023)
A number of men have forgone first-time prostate-specific antigen testing opportunities following the COVID-19 outbreak; thus, early cancer diagnoses in some individuals might have been missed. Likewise, many prostate cancer patients have forgone follow-up in the late-COVID period, which might compromise their oncologic outcomes.